Monopar Announces Positive Data On MNPR-101-Zr Tumor Targeting
12 Sep 2024 //
GLOBENEWSWIRE
FDA to re-review application for AstraZeneca’s hyperkalaemia treatment
19 Oct 2016 //
EU PHARMACEUTICAL
12 Sep 2024 //
GLOBENEWSWIRE
19 Oct 2016 //
EU PHARMACEUTICAL